PET/CT scans using an experimental prostate-specific membrane antigen (PSMA) imaging agent can identify SC nodal metastasis ...

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection) for use in patients with prostate cancer.

Research reveals men skipping prostate cancer screenings are 45% more likely to die from the disease. Evidence from a large European study indicates P ...

Short-term ADT especially benefitted patients with a baseline PSA level of more than 2 ng/mL, a PSA doubling time of less than 3 months, and a higher metastatic stage, presumably because they were ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

Patients with mCRPC prostate cancer have an elevated risk of fractures due to bone metastases and use of androgen receptor pathway inhibitors (ARPI).

Brazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix.

Journal of Nuclear Medicine March 2025, jnumed.124.269299; DOI: https://doi.org/10.2967/jnumed.124.269299 ...

and a positive family history of prostate cancer. He presented to the accident and emergency department with urinary retention and renal impairment. Imaging (CT of the abdomen and pelvis) revealed ...

Traditionally, men who chose radiation therapy for prostate cancer undergo radiation for weeks or even months. But now, in certain cases, it can be completed in less than a week. Prostate cancer ...

Materials and method: A total of 144 patients with prostate cancer who underwent preoperative MRI (T2WI and DWI) were retrospectively included. All patients were categorized into two groups based on ...